Literature DB >> 18029359

Phosphatidylinositol 3-phosphate-dependent and -independent functions of p40phox in activation of the neutrophil NADPH oxidase.

Sarah A Bissonnette1, Christina M Glazier, Mary Q Stewart, Glenn E Brown, Chris D Ellson, Michael B Yaffe.   

Abstract

In response to bacterial infection, the neutrophil NADPH oxidase assembles on phagolysosomes to catalyze the transfer of electrons from NADPH to oxygen, forming superoxide and downstream reactive oxygen species (ROS). The active oxidase is composed of a membrane-bound cytochrome together with three cytosolic phox proteins, p40(phox), p47(phox), and p67(phox), and the small GTPase Rac2, and is regulated through a process involving protein kinase C, MAPK, and phosphatidylinositol 3-kinase. The role of p40(phox) remains less well defined than those of p47(phox) and p67(phox). We investigated the biological role of p40(phox) in differentiated PLB-985 neutrophils, and we show that depletion of endogenous p40(phox) using lentiviral short hairpin RNA reduces ROS production and impairs bacterial killing under conditions where p67(phox) levels remain constant. Biochemical studies using a cytosol-reconstituted permeabilized human neutrophil cores system that recapitulates intracellular oxidase activation revealed that depletion of p40(phox) reduces both the maximal rate and total amount of ROS produced without altering the K(M) value of the oxidase for NADPH. Using a series of mutants, p47PX-p40(phox) chimeras, and deletion constructs, we found that the p40(phox) PX domain has phosphatidylinositol 3-phosphate (PtdIns(3)P)-dependent and -independent functions. Translocation of p67(phox) requires the PX domain but not 3-phosphoinositide binding. Activation of the oxidase by p40(phox), however, requires both PtdIns(3)P binding and an Src homology 3 (SH3) domain competent to bind to poly-Pro ligands. Mutations that disrupt the closed auto-inhibited form of full-length p40(phox) can increase oxidase activity approximately 2.5-fold above that of wild-type p40(phox) but maintain the requirement for PX and SH3 domain function. We present a model where p40(phox) translocates p67(phox) to the region of the cytochrome and subsequently switches the oxidase to an activated state dependent upon PtdIns(3)P and SH3 domain engagement.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18029359      PMCID: PMC2755574          DOI: 10.1074/jbc.M706639200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  The mechanism of activation of NADPH oxidase in the cell-free system: the activation process is primarily catalytic and not through the formation of a stoichiometric complex.

Authors:  A R Cross; R W Erickson; J T Curnutte
Journal:  Biochem J       Date:  1999-07-15       Impact factor: 3.857

Review 2.  Activation of the neutrophil respiratory burst oxidase.

Authors:  R A Clark
Journal:  J Infect Dis       Date:  1999-03       Impact factor: 5.226

3.  Phorbol myristate acetate induces neutrophil NADPH-oxidase activity by two separate signal transduction pathways: dependent or independent of phosphatidylinositol 3-kinase.

Authors:  A Karlsson; J B Nixon; L C McPhail
Journal:  J Leukoc Biol       Date:  2000-03       Impact factor: 4.962

4.  NADPH oxidase activation and assembly during phagocytosis.

Authors:  F R DeLeo; L A Allen; M Apicella; W M Nauseef
Journal:  J Immunol       Date:  1999-12-15       Impact factor: 5.422

5.  NADPH oxidase is functionally assembled in specific granules during activation of human neutrophils.

Authors:  C Vaissiere; V Le Cabec; I Maridonneau-Parini
Journal:  J Leukoc Biol       Date:  1999-05       Impact factor: 4.962

6.  Binding of nicotinamide adenine dinucleotide phosphate to the tetratricopeptide repeat domains at the N-terminus of p67PHOX, a subunit of the leukocyte nicotinamide adenine dinucleotide phosphate oxidase.

Authors:  P M Dang; J L Johnson; B M Babior
Journal:  Biochemistry       Date:  2000-03-21       Impact factor: 3.162

7.  NADPH dehydrogenase activity of p67PHOX, a cytosolic subunit of the leukocyte NADPH oxidase.

Authors:  P M Dang; B M Babior; R M Smith
Journal:  Biochemistry       Date:  1999-05-04       Impact factor: 3.162

Review 8.  Genetic, biochemical, and clinical features of chronic granulomatous disease.

Authors:  B H Segal; T L Leto; J I Gallin; H L Malech; S M Holland
Journal:  Medicine (Baltimore)       Date:  2000-05       Impact factor: 1.889

9.  p40(phox) Participates in the activation of NADPH oxidase by increasing the affinity of p47(phox) for flavocytochrome b(558).

Authors:  A R Cross
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

10.  Src homology 3 domain-dependent interaction of Nck-2 with insulin receptor substrate-1.

Authors:  Y Tu; L Liang; S J Frank; C Wu
Journal:  Biochem J       Date:  2001-03-01       Impact factor: 3.857

View more
  25 in total

1.  Phosphorylation of threonine 154 in p40phox is an important physiological signal for activation of the neutrophil NADPH oxidase.

Authors:  Tamara A M Chessa; Karen E Anderson; Yanhua Hu; Qingbo Xu; Oliver Rausch; Len R Stephens; Phillip T Hawkins
Journal:  Blood       Date:  2010-09-22       Impact factor: 22.113

2.  Cooperation of p40(phox) with p47(phox) for Nox2-based NADPH oxidase activation during Fcγ receptor (FcγR)-mediated phagocytosis: mechanism for acquisition of p40(phox) phosphatidylinositol 3-phosphate (PI(3)P) binding.

Authors:  Takehiko Ueyama; Junya Nakakita; Takashi Nakamura; Takeshi Kobayashi; Toshihiro Kobayashi; Jeonghyun Son; Megumi Sakuma; Hirofumi Sakaguchi; Thomas L Leto; Naoaki Saito
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

3.  Fc gamma R-stimulated activation of the NADPH oxidase: phosphoinositide-binding protein p40phox regulates NADPH oxidase activity after enzyme assembly on the phagosome.

Authors:  Wei Tian; Xing Jun Li; Natalie D Stull; Wenyu Ming; Chang-Il Suh; Sarah A Bissonnette; Michael B Yaffe; Sergio Grinstein; Simon J Atkinson; Mary C Dinauer
Journal:  Blood       Date:  2008-08-18       Impact factor: 22.113

Review 4.  Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system.

Authors:  Bernard Lassègue; Alejandra San Martín; Kathy K Griendling
Journal:  Circ Res       Date:  2012-05-11       Impact factor: 17.367

5.  Novel p47(phox)-related organizers regulate localized NADPH oxidase 1 (Nox1) activity.

Authors:  Davide Gianni; Begoña Diaz; Nicolas Taulet; Bruce Fowler; Sara A Courtneidge; Gary M Bokoch
Journal:  Sci Signal       Date:  2009-09-15       Impact factor: 8.192

6.  A conserved region between the TPR and activation domains of p67phox participates in activation of the phagocyte NADPH oxidase.

Authors:  Yuichi Maehara; Kei Miyano; Satoru Yuzawa; Risa Akimoto; Ryu Takeya; Hideki Sumimoto
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

Review 7.  New insights into the regulation of neutrophil NADPH oxidase activity in the phagosome: a focus on the role of lipid and Ca(2+) signaling.

Authors:  Sabrina Bréchard; Sébastien Plançon; Eric J Tschirhart
Journal:  Antioxid Redox Signal       Date:  2012-09-18       Impact factor: 8.401

Review 8.  Neutrophils at work.

Authors:  William M Nauseef; Niels Borregaard
Journal:  Nat Immunol       Date:  2014-07       Impact factor: 25.606

9.  Effects of F/G-actin ratio and actin turn-over rate on NADPH oxidase activity in microglia.

Authors:  Izabela Rasmussen; Line H Pedersen; Luise Byg; Kazuhiro Suzuki; Hideki Sumimoto; Frederik Vilhardt
Journal:  BMC Immunol       Date:  2010-09-08       Impact factor: 3.615

10.  A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity.

Authors:  Juan D Matute; Andres A Arias; Nicola A M Wright; Iwona Wrobel; Christopher C M Waterhouse; Xing Jun Li; Christophe C Marchal; Natalie D Stull; David B Lewis; MacGregor Steele; James D Kellner; Weiming Yu; Samy O Meroueh; William M Nauseef; Mary C Dinauer
Journal:  Blood       Date:  2009-08-19       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.